Patent ID: 7964643

Claim:
A compound selected from compounds of the following formula and pharmaceutically acceptable salts thereof: wherein Ar 1 is independently: r is independently an integer from 0 to 3; q is independently an integer from 0 to 2; and each R P is independently: —C(═O)OH, —C(═O)OMe, —C(═O)OEt, —C(═O)O(iPr), —C(═O)O(tBu), —C(═O)O(cPr), —C(═O)OCH 2 CH 2 OH, —C(═O)OCH 2 CH 2 OMe, —C(═O)OCH 2 CH 2 OEt, —C(═O)OPh, —C(═O)OCH 2 Ph, —(C═O)N H 2 , —(C═O)NMe 2 , —(C═O)NEt 2 , —(C═O)N(iPr) 2 , —(C═O)N(CH 2 CH 2 OH) 2 , —(C═O)-morpholino, —(C═O)NHPh, —(C═O)NHCH 2 Ph, —(C═O)Me, —(C═O)Et, —(C═O)(tBu), —(C═O)-cHex, —(C═O)Ph, —(C═O)CH 2 Ph, —F, —Cl, —Br, —I, —CN, —NO 2 , —OH, —OMe, —OEt, —O(iPr), —O(tBu), —OPh, —OCH 2 Ph, —OCF 3 , —OCH 2 CF 3 , —OCH 2 CH 2 OH, —OCH 2 CH 2 OMe, —OCH 2 CH 2 OEt, —OCH 2 CH 2 NH 2 , —OCH 2 CH 2 NMe 2 , —OCH 2 CH 2 N(iPr) 2 , —OPh-Me, —OPh-OH, —OPh-OMe, —OPh-F, —OPh-Cl, —OPh-Br, —OPh-I, —SH, —SMe, —SEt, —SPh, —SCH 2 Ph, —OC(═O)Me, —OC(═O)Et, —OC(═O)(iPr), —OC(═O)(tBu), —OC(═O)(cPr), —OC(═O)CH 2 CH 2 OH, —OC(═O)CH 2 CH 2 OMe, —OC(═O)CH 2 CH 2 OEt, —OC(═O)Ph, —OC(═O)CH 2 Ph, —NH 2 , —NHMe, —NHEt, —NH(iPr), —NMe 2 , —NEt 2 , —N(iPr) 2 , —N(CH 2 CH 2 OH) 2 , —NHPh, —NHCH 2 Ph, piperidino, piperazino, morpholino, —NH(C═O)Me, —NH(C═O)Et, —NH(C═O)Ph, —NHC(═O)CH 2 Ph, —NMe(C═O)Me, —NMe(C═O)Et, —NMe(C═O)Ph, —NMeC(═O)CH 2 Ph, —NH(C═O)NH 2 , —NH(C═O)NHMe, —NH(C═O)NHEt, —NH(C═O)NPh, —NH(C═O)NHCH 2 Ph, —NH(C═S)NH 2 , —NH(C═S)NHMe, —NH(C═S)NHEt, —NH(C═S)NPh, —NH(C═S)NHCH 2 Ph, —NHSO 2 Me, —NHSO 2 Et, —NHSO 2 Ph, —NHSO 2 PhMe, —NHSO 2 CH 2 Ph, —NMeSO 2 Me, —NMeSO 2 Et, —NMeSO 2 Ph, —NMeSO 2 PhMe, —NMeSO 2 CH 2 Ph, —SO 2 Me, —SO 2 CF 3 , —SO 2 Et, —SO 2 Ph, —SO 2 PhMe, —SO 2 CH 2 Ph, —OSO 2 Me, —OSO 2 CF 3 , —OSO 2 Et, —OSO 2 Ph, —OSO 2 PhMe, —OSO 2 CH 2 Ph, —SO 2 NH 2 , —SO 2 NHMe, —SO 2 NHEt, —SO 2 NMe 2 , —SO 2 NEt 2 , —SO 2 -morpholino, —SO 2 NHPh, —SO 2 NHCH 2 Ph, —CH 2 Ph, —CH 2 Ph-Me, —CH 2 Ph-OH, —CH 2 Ph-F, —CH 2 Ph-Cl, -Ph, -Ph-Me, -Ph-OH, -Ph-OMe, -Ph-F, -Ph-Cl, -Ph-Br, -Ph-I, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, furanyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, pyrrolidinyl, piperidinyl, azepinyl, tetrahydropyranyl, morpholinyl, azetidinyl, piperazinyl, imidazolinyl, piperazinedionyl, and oxazolinonyl, -Me, -Et, -nPr, -iPr, -nBu, -iBu, -sBu, -tBu, -nPe, -cPr, -cHex, —CH═CH 2 , —CH 2 —CH═CH 2 , —CF 3 , —CHF 2 , —CH 2 F, —CCl 3 , —CBr 3 , —CH 2 CH 2 F, —CH 2 CHF 2 , and —CH 2 CF 3 , —CH 2 OH, —CH 2 OMe, —CH 2 OEt, —CH 2 NH 2 , —CH 2 NMe 2 , —CH 2 CH 2 OH, —CH 2 CH 2 OMe, —CH 2 CH 2 OEt, —CH 2 CH 2 CH 2 NH 2 , and —CH 2 CH 2 NMe 2 ; and wherein R N is independently —H or C 1-7 alkyl; and wherein R alk is a fully saturated aliphatic C 4-10 alkylene group; and wherein Q is independently —OH, —O—R E1 , or —O—C(═O)—R E2 ; wherein: R E1 is independently C 1-7 alkyl; and R E2 is independently C 1-7 alkyl.